ADATAR Izrael - angličtina - Ministry of Health

adatar

taro international ltd, israel - adapalene; benzoyl peroxide as hydrous - gel - benzoyl peroxide as hydrous 2.5 %w/w; adapalene 0.1 %w/w - adapalene - cutaneous treatment of acne vulgaris when comedones, papules and pustules are present

PITRIYA-T Izrael - angličtina - Ministry of Health

pitriya-t

taro international ltd, israel - terbinafine hydrochloride - cream - terbinafine hydrochloride 1 %w/w - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum) microsporum canis and epidemophyton floccosum. yeast infections of the skin principally those caused by the genus candida (e.g. candida albicans). pityriasis (tinea versicolor) due to pityrosporum orbiculare (also known as malassezia furfur). for the treatment of plantar-type tinea pedis (moccasin type).

TARIOL Izrael - angličtina - Ministry of Health

tariol

taro international ltd, israel - betamethasone as dipropionate; calcipotriol as monohydrate - gel - calcipotriol as monohydrate 50 mcg / 1 g; betamethasone as dipropionate 0.5 mg / 1 g - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

LATARO Izrael - angličtina - Ministry of Health

lataro

taro international ltd, israel - latanoprost - eye drops, solution - latanoprost 0.05 mg / 1 ml - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

ODOMZO  200 MG Izrael - angličtina - Ministry of Health

odomzo 200 mg

taro international ltd, israel - sonidegib as diphosphate - hard capsule - sonidegib as diphosphate 200 mg - sonidegib - odomzo 200 mg is indicated for the treatment of adult patients with locally advanced basal cell carcinoma which cannot be treated with curative surgery or radiation therapy

TERIFLUNOMIDE TARO Izrael - angličtina - Ministry of Health

teriflunomide taro

taro international ltd, israel - teriflunomide - film coated tablets - teriflunomide 14 mg - teriflunomide - for the treatment of adult patients with relapsing remitting forms of multiple sclerosis (ms) ) to reduce the frequency of clinical relapses and to delay the progression of physical disability.

CURATANE 40 MG Izrael - angličtina - Ministry of Health

curatane 40 mg

taro international ltd, israel - isotretinoin - capsules soft gelatin - isotretinoin 40 mg - isotretinoin - for the treatment of severe cystic acne that does not respond to other treatment.

CURATANE 5 MG Izrael - angličtina - Ministry of Health

curatane 5 mg

taro international ltd, israel - isotretinoin - capsules soft gelatin - isotretinoin 5 mg - isotretinoin - for the treatment of severe cystic acne that does not respond to other treatment

RIVAROXABAN TARO 15 MG Izrael - angličtina - Ministry of Health

rivaroxaban taro 15 mg

taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

RIVAROXABAN TARO 20 MG Izrael - angličtina - Ministry of Health

rivaroxaban taro 20 mg

taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - * prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack.* treatment of deep vein thrombosis (dvt), and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing 50 kg after at least 5 days of initial parenteral anticoagulation treatment.